Linked Life Data

15478050

Source:http://linkedlifedata.com/resource/pubmed/id/15478050

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
2004-10-12
pubmed:abstractText
Epithelial ovarian cancer is the leading cause of death from gynaecologic malignancies in western countries. In the clinical day treatment decision of the physician (e. g. surgery, chemotherapy) based on individual prognostic factors of the patient with ovarian cancer. The tumor stage at time of diagnosis and the postoperative residual tumor mass are prognostic factors and are unequivocally related to overall survival. Other prognostic factors are identified mostly in small series and are discussed in the literature controversially. This article discussing the value of conventional prognostic factors, as stage, postoperative tumor mass, age, lymph node status, ascites) and newer molecular biological factors, as Her-2-status, PAI-1, MMP, VEGF and CD24.
pubmed:language
ger
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0044-4197
pubmed:author
pubmed:issnType
Print
pubmed:volume
126
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
315-22
pubmed:dateRevised
2008-2-11
pubmed:meshHeading
pubmed:year
2004
pubmed:articleTitle
[Conventional and experimental prognostic factors in ovarian cancer].
pubmed:affiliation
Universitätsklinikum Charité/Medizinische Fakultät der Humboldt-Universität zu Berlin, Klinik für Frauenheilkunde und Geburtshilfe/Campus Virchow-Klinikum. Sehouli@aol.com
pubmed:publicationType
Journal Article, English Abstract, Review